Adiponectin levels are downregulated under adverse metabolic conditions, as adverse fat distribution and adipose tissue dysfunction typical of obesity status, resulting in decreased adiponectin plasma levels [79]. This evidence concerns the gene ADIPOQ and obesity disorder.